Table 1.
Analyte | Presence of mtDNA | No. of patients (%) | RF+ | Erosivity | ExART | CRP (mg/l) | TPC (×109/l) | LPC (×109/l) |
Synovial fluid | Yes | 38 (70%) | 33 (87%) | 32 (84%) | 13 (34%) | n.d. | n.d. | 7.8 ± 0.5 |
No | 16 (30%) | 10 (63%) | 10 (63%) | 4 (25%) | n.d. | n.d. | 8.6 ± 0.8 | |
Blood | Yes | 30 (56%) | 24 (80%) | 26 (87%) | 8 (27%) | 38 ± 6 | 354 ± 25 | 7.9 ± 0.6 |
No | 24 (44%) | 19 (79%) | 16 (67%) | 7 (29%) | 45 ± 12 | 357 ± 29 | 8.1 ± 0.6 |
RA, rheumatoid arthritis; RF, rheumatoid factor; ExART, having extra-articular manifestations of RA; CRP, C-reactive protein; TPC, thrombocyte particle count; LPC, leukocyte particle count, n.d., not done.